CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer

Stacey Shiovitz, Monica M. Bertagnolli, Lindsay A. Renfro, Eunmi Nam, Nathan R. Foster, Slavomir Dzieciatkowski, Yanxin Luo, Victoria Valinluck Lao, Raymond J. Monnat, Mary J. Emond, Nancy Maizels, Donna Niedzwiecki, Richard M. Goldberg, Leonard B. Saltz, Alan Venook, Robert S. Warren, William M. Grady

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences